title: [Coronary disease and hormonal treatment during the perimenopausal period].
abstract: Hormone replacement therapy (HRT) is widely recognized as probably most advisable treatment of perimenopausal women with cardiovascular disorders. Whenever HRT is administered for gynecological reasons, special attention should be paid to the presence of cardiological risk factors as these may be potentiated by high doses of gestogens. The authors undertake this problem inspired by a cases of a 53-years old patient (given oral lynestrol fair persisting uterine bleedings) who suffered from several complications, including venous thrombosis and myocardial infarction.
authors.affiliation: Kliniki Kardiologii Akademii Medycznej w Warszawie.
authors.forename: M
authors.initials: M
authors.lastname: Jedras
authors.forename: S
authors.initials: S
authors.lastname: Stawicki
authors.forename: T
authors.initials: T
authors.lastname: Mroczka
authors.forename: Z
authors.initials: Z
authors.lastname: Tomik
authors.forename: P
authors.initials: P
authors.lastname: Stolarz
mesh_terms: D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000000981:diagnostic imaging; D017697:Premenopause; D045167:Progesterone Congeners / Q000009:adverse effects*; D012307:Risk Factors; D013924:Thrombophlebitis / Q000139:chemically induced*; D014463:Ultrasonography; D014592:Uterine Hemorrhage / Q000188:drug therapy
chemical_list: D045167:Progesterone Congeners; D008234:Lynestrenol